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Introduction: Because of concern about increasing health care costs, we
undertook a study to find patient risk factors associated with increased
hospital costs and to evaluate the relationship between increased cost and
in-hospital mortality and serious morbidity. Methods: More than 100 patient
variables were screened in 1221 patients undergoing cardiac procedures.
Simultaneously, patient hospital costs were computed from the cost-to-charge
ratio. Univariate and multivariate statistics were used to explore the relation-
ship between hospital cost and patient outcomes, including operative death,
in-hospital morbidity, and length of stay. Results: The greatest costs were for 31
patients who did not survive operation ($74,466, 95% confidence interval
$27,102 to $198,025), greater than the costs for 120 patients who had serious,
nonfatal morbidity ($60,335, 95% confidence interval $28,381 to $130,897, p 5
0.02) and those for 1070 patients who survived operation without complication
($31,459, 95% confidence interval $21,944 to $49,849, p 5 0.001). Breakdown of
the components of hospital costs in fatalities and in cases with nonfatal
complications revealed that the greatest contributions were in anesthesia and
operating room costs. Significant (by stepwise linear regression analysis)
independent risks for increased hospital cost were as follows (in order of
decreasing importance): (1) preoperative congestive heart failure, (2) serum
creatinine level greater than 2.5 mg/dl, (3) New York state predicted mortality
risk, (4), type of operation (coronary artery bypass grafting, valve, valve plus
coronary artery bypass grafting, or other), (5) preoperative hematocrit, (6)
need for reoperative procedure, (7) operative priority, and (8) sex. These risks
were different than those for in-hospitality death or increased length of stay.
Hospital cost correlated with length of stay (r 5 0.63, p < 0.001), but there were
many outliers at the high end of the hospital cost spectrum. Conclusions: We
conclude that operative death is the most costly outcome; length of stay is an
unreliable indicator of hospital cost, especially at the high end of the cost
spectrum; risks of increased hospital cost are different than those for periop-
erative mortality or increased length of stay; and ventricular dysfunction in
elderly patients undergoing urgent operations for other than coronary disease
is associated with increased cost. Certain patient factors, such as preoperative
anemia and congestive heart failure, are amenable to preoperative intervention
to reduce costs, and a high-risk patient profile can serve as a target for
cost-reduction strategies. (J Thorac Cardiovasc Surg 1998;115:593-603)
Health care costs accounted for only 2% of thegross domestic product in 1965, but 14% in
1994.1 This dramatic rise in health care costs has
prompted interest and concern about the allocation
and use of health care dollars. Cardiac operations
are a logical target for initiatives aimed at decreas-
ing health care costs, because coronary artery bypass
grafting (CABG) accounts for more health care
dollars than any other surgical procedure in the
United States.2 Hospital costs for cardiac proce-
dures have been evaluated,3-5 and some of the risks
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associated with increased resource use have been
identified.6-11 However, the exact relationship of
patient risk factors to hospital cost is poorly under-
stood. This is alarming, because external forces may
mandate cost limitation and ultimately deny care to
patients at high risk. To determine which patients
are at high risk for excessive hospital cost and to
understand the relationship between hospital cost
and other outcomes (morbidity and mortality), we
undertook a study to evaluate the risks for high costs
and to define the relationship between costs of
cardiac operation and hospital outcome. Our ulti-
mate goal is to generate a profile for patients at high
risk for excessive hospital costs and to modify the
patient risk factors and reduce hospital costs.
Methods
Patient database. Patients undergoing cardiac proce-
dures in 1994 were entered into the study group. A total of
1221 patients were studied. Data were gathered prospec-
tively and concurrently during the patients’ hospital stays.
Data were obtained from patient records by research
nurses who were given strict criteria to determine out-
come variables (stroke, perioperative myocardial infarc-
tion, sepsis, respiratory failure, postoperative bleeding,
low cardiac output necessitating intraaortic balloon coun-
terpulsation, and renal failure) as well as to determine
preoperative variables. A few patient records were incom-
plete, but more than 98% of all data elements for each
patient were available for analysis. Incomplete records
were not included in the study. More than 100 patient
variables were evaluated for each patient undergoing
operation. All database elements were gathered by an
independent observer (a research nurse hired by the
institution). These variables are included in a database
maintained by the institution and used as part of the New
York State cardiac surgery database. The New York State
cardiac surgery database is used to generate hospital-
specific and surgeon-specific risk-adjusted mortality rates,
which are routinely published in the lay press. Appendix 1
lists significant variables and their definitions used to
calculate predicted operative mortality rates for New
York State risk adjustment methodology.
An estimated mortality risk for each patient was calcu-
lated according to the New York State risk adjustment
system. This method of risk adjustment has only been
validated for CABG procedures.12-14 The study group
included all patients undergoing cardiac procedures re-
quiring cardiopulmonary bypass, not just patients under-
going CABG. Many of the risk factors for death in
patients undergoing procedures other than coronary re-
vascularization are similar to those in patients undergoing
CABG (Appendix 2). Such variables as ventricular dys-
function, advanced age, and urgency of operation are
important risk factors for death both in patients undergo-
ing coronary revascularization and in those undergoing
other cardiac procedures.15 For comparison purposes, the
New York State mortality risk score for CABG was
therefore used as an approximation of predicted mortality
Fig. 1. Relationship between hospital costs and LOS.
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rate for the study group, which underwent a variety of
operations, not only CABG.
Determination of hospital costs from charges. Hospital
costs were computed from the cost to charge ratio. There
are a total of 32 cost centers in the institution, including
operating room, anesthesia, room and board, pharmacy,
microbiology, blood bank, chemistry, and hematology.
Each person responsible for administration of an individ-
ual cost center identified the true direct and indirect costs
within that cost center. The ratio for each cost center was
used to compute the estimated true costs per patient
undergoing cardiac surgery in 1994, and the cost estimates
for each cost center were summed to obtain the total
hospital costs per patient. To facilitate analysis, the dif-
ferent cost centers were grouped into seven different cost
groups as follows: (1) pathology, costs including hematol-
ogy, chemistry, blood bank; (2) cost of room and board;
(3) anesthesia costs, including perfusion apparatus; (4)
operating room costs, including disposables and personnel
costs but not physician fees; (5) drugs and pharmacy costs;
(6) cardiology costs, including telemetry, electrocardio-
grams, and postoperative diagnostic studies; and (7) mis-
cellaneous costs, including radiologic, gastrointestinal,
renal, physical medicine, emergency department, and
noninvasive vascular studies. Professional fees were not
included in the computed costs.
Statistical methods. Univariate and multivariate statis-
tical methods were used for examination of the study
group. Four outcomes were measured: (1) hospital cost,
(2) length of stay (LOS), (3) in-hospital death, and (4)
serious in-hospital morbidity (stroke, perioperative myo-
cardial infarction, sepsis or deep sternal infection, low
cardiac output necessitating intraaortic balloon counter-
pulsation or a left ventricular assist device, renal failure,
or pulmonary failure). All variables in the database were
screened for relevance to each of the outcomes and for
variable interactions.16
Hospital costs in the various patient outcome groups
(deaths, morbidities, and uncomplicated courses) were
compared with one-way analysis of variance. Intergroup
comparisons were made with adjusted t tests. Similar
univariate statistical methods were used to analyze the
relationship between LOS and outcome.
Linear regression analysis was used to determine the
correlation between hospital cost and LOS. The Pearson
correlation coefficient was calculated from the regression
line, and an analysis of residuals was performed to deter-
mine the quality of the regression.
A stepwise multivariate linear regression model was
used to find independent predictors of increased hospital
cost (BMDP Statistical Software, Sepulveda, Calif.). Only
preoperative variables were included in the multivariate
models. Intraoperative or postoperative variables, such as
ischemic time, chest tube drainage, amount of blood
products consumed, or number of bypass grafts, were not
entered into the multivariate models because it would be
difficult to estimate the value of these variables before the
operation for a predictive model. Variables were entered
into the linear regression model in a stepwise manner,
with a univariate contingent probability of 0.10 or less
used to enter variables and a p value lower than 0.15 used
to remove variables from the model. A Cox regression
model was used to find independent risk factors for
increased LOS. Postoperative deaths were considered
censored events for the purposes of the Cox regression.
For operative death, a logistic regression model with
stepwise addition of variables was used to determine
independent predictors of operative death. A contingent
probability of 0.10 or less was used to enter variables into
the logistic model in a forward-stepping manner, and a
contingent probability of 0.15 or less was used to remove
variables from the model.
Results
Hospital cost and outcome. Hospital cost was
compared for each of three different patient out-
comes, operative death, serious postoperative mor-
bidity, and uncomplicated postoperative course. Sig-
nificant differences were found between costs in
uncomplicated cases and those in fatalities (p 5
0.001 by analysis of variance and adjusted t test) and
patients with serious morbidity (p 5 0.004). Hospital
costs in uncomplicated cases averaged $31,579 (95%
confidence interval [CI] $21,944 to $49,849). Costs
in patients who had serious morbidity averaged
$60,335 (95% CI $28,381 to $130,897), versus an
average cost of $74,466 (95% CI $27,102 to $198,025)
in patients who did not survive operation. In general
the worse the outcome, the higher the hospital cost.
LOS and outcome. Hospital LOS is not related to
surgical outcome in the same way as hospital cost; a
similar direct relationship between the seriousness
of the various outcomes and hospital LOS does not
exist. Patients with uncomplicated courses remained
hospitalized for a mean of 8.3 days (95% CI 0 to 71
days), whereas patients with morbid complications
stayed in the hospital an average of 18.2 days (95%
Table I. Independent risk factors for excessive
hospital cost determined by stepwise linear regression
model
Predictor variables
Stepwise
regression
coefficient Change in r2 t Test
Preoperative CHF 1114 0.0947 126.90
Creatinine .2.5 mg/dl 25634 0.0564 80.50
New York State predicted
mortality risk
99930 0.0436 65.49
Type of operation
(CABG, valve, valve
with CABG or other)
5731 0.0402 63.56
Preoperative hematocrit 706 0.0278 45.61
Reoperative procedure 5416 0.0068 11.33
Priority (elective, urgent,
or emergency)
3117 0.0064 10.68
Sex 2650 0.0031 5.15
CHF, Congestive heart failure.
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CI 5.5 to 47.5 days) and patients who died did so an
average of 14.2 days (95% CI 0 to 71 days) after
operation. There was a significant difference in LOS
between complicated and uncomplicated cases (p 5
0.01 by analysis of variance with corrected t test), but
not between fatalities and uncomplicated cases (p 5
0.48 by analysis of variance).
Relationship between cost and hospital LOS.
The relationship between cost and LOS is depicted
in Fig. 1. The Pearson correlation coefficient for this
relationship is 0.63 (p , 0.001 ), Residual analysis of
the regression in Fig. 1 suggests that outliers from
the regression line are part of the natural variation
of the two outcome variables, cost and LOS,
Multivariate analysis of risk factors for increased
cost. Stepwise linear regression analysis was used to
model independent preoperative risks for incurring
increased hospital costs. Significant predictor vari-
ables in the model are shown in Table I. The
variables are listed in order of their relative contri-
bution to the linear regression equation.
Hospital cost and risk for operative death. The
relationship of hospital cost to the operative mor-
tality risk is shown in Fig. 2. There is a surprisingly
poor correlation between cost and predicted mor-
tality risk. Even though the mortality risk (as repre-
sented by the New York State predicted mortality
risk scoring system) is a significant multivariate
predictor of increased cost, there is poor direct
correlation between these two variables. Many pa-
tients with a less than 2% predicted risk of death
had hospital costs in excess of $100,000.
Hospital cost and type of operation. The type of
operative procedure alters hospital cost. Fig. 3
shows the change in average hospital cost with the
type of operation performed. Operations other than
coronary revascularization are associated with sig-
nificantly increased costs compared with isolated
coronary revascularization.
Components of increased hospital cost. The hos-
pital cost per patient was the summation of cost from
each of the 32 different cost centers within the institu-
tion. The different cost centers were reduced into
seven different groups to facilitate analysis (see Meth-
ods). Fig. 4 shows the contribution to total costs from
each of the seven major groups for the various out-
comes. More than 80% of hospital costs were from five
cost centers: (1) pathology (including hematology,
chemistry, and blood bank), (2) room and board, (3)
anesthesia, (4) operating room expenses, and (5) phar-
macy costs. The proportional contributions to costs for
each of the cost centers were slightly different for
patients who did not survive operation. For the group
as a whole and for all patients who survived operation,
Fig. 2. Relationship between hospital cost and the New York State predicted mortality risk. There is poor
direct correlation between these two variables. NY, New York.
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the anesthesia and operating room costs made up the
largest single component of total cost. In the case of
operative fatalities, however, the biggest single com-
ponent of cost was not operating room expenses but
pathology costs (including blood bank, chemistry, he-
matology, and other costs).
Risks for death and increased LOS. Multivariate
risks associated with other postoperative outcomes
(death and LOS) were determined for comparison
with the risks associated with hospital cost. Table II
summarizes the results of Cox proportional hazards
regression analysis to determine risks for hospital
LOS, and Table III summarizes logistic regression
results to determine risks for increased operative
mortality rate. The risk factors for both operative
death (Table III) and prolonged hospital LOS (Ta-
ble II) are different than those for increased hospital
cost (Table I).
Some of the relative risks for significant variables
associated with increased LOS (shown in Table II)
are less than 1. This indicates that the presence of
one or more of these risks in a case reduces the
chance of minimizing hospital LOS before discharge
or in-hospital death.
Conclusions
This study demonstrates the patient risk factors
associated with increased hospital cost after cardiac
operations. Consideration of these risk factors sug-
gests that frail (anemic), elderly patients with ven-
tricular dysfunction undergoing urgent operations
other than coronary revascularization are at partic-
ularly high risk for incurring excessive hospital costs.
This result is not surprising and appeals to the
intuitive view of experienced surgeons, who use the
“eyeball test” to estimate the risk of incurring high
cost. A careful scrutiny of the risk factors associated
with high cost suggests that only a few are amenable
to preoperative intervention to reduce costs. At-
tempts to improve preoperative anemia (by increas-
ing preoperative hematocrit) and to improve con-
gestive heart failure will probably decrease cost,
especially if the operation can be converted to an
elective procedure. Although this is an intriguing
hypothesis, it must be treated as such until tested in
controlled trials.
The most costly outcome in our study is operative
death, and the biggest component of cost in fatali-
ties is laboratory (not operating room) cost. This
somewhat surprising result warrants comment. Of
the 31 patients who did not survive operation, only
three died in the operating room. Many of the
others died after prolonged intensive care unit and
hospital stays. This results in the variability of costs
in these patients being spread across a wide range,
as can be appreciated from the CIs. The contribu-
tions to hospital cost shown in Fig. 4 suggest that
operating room and anesthesia costs are fairly con-
stant regardless of outcome. However, the sickest
patients who eventually die after operation consume
significantly increased resources largely composed
of laboratory costs, including blood bank expenses,
and other non–operating room costs. Operative
death is associated with increased cost, but the
Fig. 3. Variation of hospital cost with type of operation performed. The more complex the operation, the
greater the hospital cost. Error bars represent the 95th percentile CI for each type of operative procedure.
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prognostic significance of this finding is uncertain.
The variables that predict operative death in our
study are few (Table III). A similar observation was
made by Jones and coworkers,17 who found that a
relatively small number of clinical variables provide
a large amount of prognostic information for oper-
ative death in patients undergoing CABG. Unfortu-
nately, a high risk of operative death is not enough
to suggest high cost. Many patients with high costs
had relatively low risks of operative death; con-
versely, some patients with high predicted operative
mortality risks did not have excessive hospital costs.
Our results suggest that the preoperative predicted
mortality risk is not the key item associated with
high cost, but the care of the sickest patients after
operation in the intensive care unit and elsewhere is
an important component of increased cost for pa-
tients who do not survive operation. The difficulty in
predicting which patients will die and have high
costs makes it unwise and inappropriate to limit
access to care solely on the basis of predicted
operative mortality risk.
The exact relationship between hospital operative
costs and in-hospital morbidity and mortality is not
clear. If mandated limitation of health care re-
sources becomes a reality, one cost-cutting maneu-
ver may be to limit spending on patients with highest
predicted operative mortality risks. There is, how-
ever, no clear-cut documentation that the patients
with high postoperative morbidity or mortality risks
have the worst cost-benefit relationship. No conclu-
sive evidence exists that patients at high risk who
consume the most hospital resources benefit the
least from high-cost care. In fact, some preliminary
evidence suggests that patients at very high risk
surviving third operations for coronary artery dis-
ease have surprisingly limited hospital costs and
good long-term benefits from reoperation.18 On the
other end of the spectrum, we found that many
patients with a less than 2% predicted operative
mortality risk have increased hospital costs, in excess
of $100,000 (Fig. 5). Even though mortality risk is an
independent, multivariate factor associated with in-
creased cost, there is poor direct correlation be-
tween cost and predicted operative mortality risk.
Before difficult decisions about limitation of care
can be made, adequate information about the rela-
tionship between hospital cost and morbidity or
mortality must be available.
Many patients with a less than 2% predicted
mortality risk have hospital costs in excess of
$100,000. Mortality risk is an independent predictor
Fig. 4. Components of total hospital costs for each of the various outcomes. Misc, Miscellaneous; Anesth,
anesthesia; Cardiol, cardiology; Rm/Bd, room and board; Path, pathology; OR, operating room; Comp,
complicated course; Uncomp, uncomplicated course.
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of increased hospital cost; however, as Fig. 2 sug-
gests, predicted operative mortality risk does not
correlate directly with hospital cost. How can a
variable such as mortality risk be both an important
independent multivariate predictor of increased cost
and a poor direct predictor of hospital cost? There
are several possible explanations of this finding. One
possibility is that the New York State mortality risk
scoring system used to predict operative mortality
risk for patients undergoing CABG is not an accu-
rate reflection of operative risk for patients under-
going procedures other than coronary revasculariza-
tion. Another possibility is related to the principles
of multivariate statistical techniques and of variable
interaction. For example, hospital costs for a patient
with a low predicted operative mortality risk may
turn out to be unexpectedly greater if the patient
also has congestive heart failure and requires a
complex operation (a procedure other than simple
valve replacement or first-time coronary revascular-
ization). Variable interactions of this sort are ad-
justed for by the regression model presented here,
and resultant regression models are more likely to
reflect the true state of nature than simple compar-
ison of the predicted operative risk with hospital
cost as in Fig. 2.
The results presented here can be used to infer
details of the relationship between costs of opera-
tion and LOS. The correlation coefficient for the
regression line between LOS and cost is 0.63, sug-
gesting that LOS is a moderately good predictor of
cost. In statistical parlance, the results shown in Fig.
1 suggest that cost, especially at the high end of the
cost spectrum, is not totally accounted for by LOS.
An example can be seen by considering some of the
details shown in Fig. 1. Two patients had a total
hospital cost of $150,000 each and stayed in the
hospital less than 20 days, whereas two other pa-
tients had similar hospital costs but stayed in the
hospital more than 80 days each. This example
suggests that the relationship between LOS and cost
is least predictable for patients who consume the
greatest share of resources.
The profile of a patient at high risk for excessive
hospital cost suggests a patient with advanced car-
diac disease (e.g., congestive heart failure, high
mortality score, reoperative procedure, and a com-
bination of valvular and coronary artery disease).
The only significant noncardiac comorbidities that
contribute to increased hospital cost are preopera-
tive renal dysfunction and anemia. Sex is also a
significant factor. This profile differs from that of a
patient at high risk for prolonged LOS. The risk
profile for LOS contains more comorbidities, such
as chronic obstructive pulmonary failure, hyperten-
sion, renal dysfunction, and previous stroke. This
difference between LOS and hospital costs suggests
that surviving patients with multiple risks for pro-
longed LOS do not necessarily have proportionately
Table II. Results of Cox regression model to
determine independent risks of hospital LOS in 1221
patients undergoing cardiac procedures during 1994
Variable
Relative risk
(standard error)
x2
Improvement
p
Value
New York State
predicted mortal-
ity risk (per 1%
increased mortal-
ity risk)
22.9274 (1.1280) 65.947 ,0.001
Type of operation
(not CABG)
0.2777 (0.0428) 48.646 ,0.001
Age (per 1-year in-
crease in age)
20.0154 (0.0028) 26.682 ,0.001
Preoperative hemat-
ocrit (per 1% in-
crease in hemato-
crit)
0.0258 (0.0057) 25.204 ,0.001
Creatinine greater
than 2.5 mg/dl
20.7013 (0.02085) 21.337 ,0.001
CHF 20.1798 (0.0787) 9.102 0.003
Hypertension 20.1653 (0.0640) 5.935 0.015
Ejection fraction
(per 1% change
in ejection frac-
tion)
0.0042 (0.0021) 3.839 0.050
Previous stroke 20.2320 (0.1245) 3.454 0.063
COPD 20.2583 (0.0867) 3.460 0.063
CHF, Congestive heart failure.
Table III. Summary of logistic regression model to
determine independent risks of operative death in
1221 patients undergoing cardiac procedures during
1994
Variable
Relative risk
(95% CI)
x2
Improvement
p
Value
CHF 9.20 (6.02–14.0) 43.743 ,0.001
Emergency transfer to
OR after catheteriza-
tion
18.6 (7.42–46.6) 11.029 0.001
Type of operation (not
CABG)
6.04 (3.48–10.5) 15.939 0.001
New York State
predicted mortality
rate
1.28 (1.16–1.41) 4.563 0.033
CHF, Congestive heart failure; OR, operating room.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 3
Ferraris, Ferraris, Singh 5 9 9
higher costs. Others have noticed a dichotomy be-
tween LOS and hospital cost. Kay and coworkers19
found that hospital costs were roughly proportional
to preoperative ejection fraction but LOS was not.
The exact relationship between LOS and hospital
cost is complex and is least predictable at the
extremes of the hospital cost spectrum. Care should
be taken in using improvement in LOS to infer
reduced hospital costs.
In addition, because variable profiles that predict
prolonged LOS are more likely to contain noncar-
diac comorbidities than are profiles that predict
hospital cost and because cost and LOS share a
complex relationship, limiting care for patients with
multiple noncardiac comorbidities may not have as
profound an effect on cost-containment as intu-
itively expected. Similar conclusions were reached
by Parsonnet and coworkers,20 who evaluated hos-
pital costs of patients stratified according to risk of
operative death. These authors found that exclusion
of high-risk cases from operation will result in only
a minimal cost saving, perhaps as low as 2% of the
total hospital costs for coronary revascularization.
Our study uses adjusted patient charge data to
infer costs. Others have used patient charges to
make conclusions about hospital cost.3, 8, 21-23 A
discrepancy between cost-based and charge-based
hospital costs has been noted.24, 25 Hlatky and co-
workers25 suggest that methods used to compute
cost (e.g., inclusion or exclusion of estimated hospi-
tal overhead cost) can have significant impact on
cost analysis and that economic cost savings can be
overestimated by using charge data. Similarly Cohen
and associates24 found significant difference be-
tween cost-based and charge-based accounting
methods and therefore recommend caution in using
charge-based data to judge and implement cost-
effectiveness strategies.
Unfortunately, most hospitals do not have a well-
established cost-accounting system in place and cannot
evaluate true hospital costs. This is astonishing, given
the importance of escalating medical costs. The most
basic tenet of any industrial process is a clear assess-
ment of operating cost. This is necessary to judge
outcome (profits) and to implement cost-effective
strategies. Hospitals in particular, and health care
providers in general, have been remiss in avoiding this
concept that industry uses as a fundamental starting
point for successful outcome. Accurate cost data pro-
vide the single most important piece of information
that is almost uniformly lacking in hospitals today.
More than anything else, the take-home message from
our study is that accurate cost data are necessary
before any cost-cutting strategies can be implemented.
Relative comparisons with charge-based accounting,
such as we used, are useful as a first approximation,
but interventions aimed at cost saving should be based
on true cost-accounting methods. This is particularly
true because charges are changing at a rapid rate and
are basically mandated without much concern for true
costs. This situation is made worse because true costs
are not usually known and are only estimated.
We found a set of multivariate risk factors asso-
ciated with increased hospital cost. These risk fac-
tors allow definition of a high-risk profile that can
serve as a target for cost-cutting strategies. Preop-
erative risk factors that may be amenable to inter-
vention to limit hospital cost include preoperative
anemia and congestive heart failure. Multivariate
risks for increased hospital cost are different than
those for increased LOS and for operative death.
The relationship between hospital cost and outcome
suggests that the greatest cost occurs for patients
who do not survive operation, but the exact relation-
ship between cost and outcome is complex. The
relationship between hospital cost and LOS is also
complex, so much so that improvements in LOS may
not necessarily be associated with decreased cost.
The components that make up hospital costs seem
to be different for patients who do not survive
operation than for those who do. Future refine-
ments in deriving true hospital costs (from cost-
accounting techniques) will be an important step
toward implementing cost-cutting strategies.
We thank Mrs. Ruth Myers for excellent technical
support in preparing the manuscript.
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Appendix 1. Variables and definitions used in the study group
Variable Definition
Mean or %
with variable 95% CI
Outcome variables
Mortality In-hospital death 2.54% 0.008%
LOS (days) Days from operation to discharge or death 9.43 0.46
Hospital cost (dollars) Estimated per-patient hospital cost computed from cost to
charge ratio validated by cost-accounting assessment
$35,389 $1153
Morbidity One or more of the following: stroke, MI, sepsis, low cardiac
output necessitating IABP or LVAD, renal failure, or pulmo-
nary failure
11.6% 1.8%
Continuous variables
Age (yr) Age in years 64.5 0.6
Preoperative hematocrit Hematocrit measured 24 hours before operation 39.7% 0.3%
Preoperative platelet count Plate count measured 24 hours before operation (number/liter) 241 4
BSA (m2) BSA estimated from nomogram of body weight, height and
gender
1.97 0.02
Ejection fraction Ejection fraction measured from preoperative catheterization 49.9% 0.8%
New York State mortality risk Predicted probability of death estimated from the New York
State risk-adjusted mortality score (see Appendix 2)
2.46% 0.2%
Discrete variables
Female Percentage of patients who were female 31.6% 2.6%
Left main coronary artery disease Left main coronary artery obstruction $90% 5.2% 1.2%
Fresh MI MI within 7 days before operation 50% 2.8%
Emergency OR Operation performed in next available OR after diagnosis made 4.8% 1.2%
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Discussion
Dr. Floyd D. Loop (Cleveland, Ohio). This article is
germane to all thoracic surgeons because of several shifts
in the medical market. We have shifts from supply to
demand, from public to private, and from labor-intensive
to capital-intensive health care. Physicians have assumed
the economic risk, but there is one important principle
that physicians are still reluctant to accept: price drives
cost. Cost is simply a derivative of use.
The methodology, as Dr. Ferraris pointed out, is not the
most precise estimate of cost because it assumes consis-
tent pricing and markup policies. It is much better to have
a real-time cost-accounting system, which is available
today.
The authors’ contentions that cost does not correlate
well with LOS and that for certain subsets of patients
laboratory costs and other costs are greater than surgery
costs seem counterintuitive, and they certainly defy the
conclusions presented by most in the literature on the
subject. In fairness to the authors, however, they describe
a very heterogeneous population.
The principal cost variables include disease severity,
staffing, overhead, supplies, and time. In coronary artery
surgery, the variables affecting severity are age, emergency
procedures, reoperations, and renal status. There are
others, but these four generally turn up in most analyses.
Appendix 1. Cont’d
Variable Definition
Mean or %
with variable 95% CI
Re-op 1 First reoperative procedure 8.5% 1.6%
Re-op 2 Second reoperative procedure 0.98% 0.55%
Previous stroke Stroke resulting in permanent deficit 6.7% 1.4%
Femoral popliteal disease Arterial obstruction of .50% in the femoral popliteal distribu-
tion documented by arteriogram or noninvasive diagnostic
study
22.5% 2.5%
Type of operation Classified into one of four categories: (1) CABG, (2) valve, (3)
valve/CABG, (4) other
81.0% 2.2%
Preoperative shock Hypotension necessitating pressor therapy or IABP for mainte-
nance of blood pressure
0.32% 0.2%
Hypertension Diastolic hypertension necessitating medication for control 65.5% 2.7%
Unstable angina Rest angina necessitating intravenous nitroglycerine for control 11.7% 1.8%
LVH LVH documented by preoperative electrocardiogram 12.1% 1.8%
CHF Preoperative heart failure necessitating treatment during the
same admission that CABG was performed
9.7% 1.7%
Ventricular arrhythmias V-tack or V-fib requiring cardioversion or documented episode
of sudden death
1.3% 0.7%
COPD Chronic lung disease necessitating bronchodilator or steroid
therapy
13.6% 1.9%
Diabetes Glucose intolerance necessitating oral or injectable
medication
23.8% 2.4%
Renal failure Dialysis dependence 1.4% 0.7%
Renal dysfunction Creatinine .2.5 but without dialysis 2.6% 0.9%
Immune deficit AIDS or drug-induced immune deficit 2.2% 0.8%
Cath crash Emergency transfer to OR after diagnostic catheterization 0.9% 0.5%
PTCA crash Emergency transfer to OR after failed PTCA 1.2% 0.6%
MI, Myocaridal infarction; IABP, intraaortic balloon pulsation; LVAD, left ventricular assist device; BSA, body surface area; OR, operating room; Re-op,
reoperation; LVH, left ventricular hypertrophy; CHF, congestive heart failure; V-tack, ventricular tachycardia; V-fib, ventricular fibrillation; COPD, chronic
obstructive pulmonary disease; AIDS, acquired immunodeficiency syndrome; Cath, catheterization; PTCA, percutaneous transluminal coronary angioplasty.
Appendix 2. Risk factors and relative risks for
variables that contribute to mortality risk, computed
from the New York State risk-adjusted mortality
score for surgeons and hospitals [486, 612, 621]
Risk factor
Relative risk of
operative death
None 1.000
Age 0.480
Body surface area 211.816
MI within 6 hours of operation 8.093
Persistent ventricular arrhythmias 5.777
Ejection fraction ,0.20 9.558
Ejection fraction between 0.20 and 0.39 4.705
Unstable hemodynamic state (IABP or pressors) 12.158
Shock 20.032
COPD 3.822
Diabetes 4.821
Dialysis-dependent renal failure 9.890
Previous stroke 5.928
Canadian Coronary Score (class IV only) 5.960
Femoral/popliteal vascular disease 6.171
Previous heart operation 10.949
MI, Myocardial infarction; IABP, intraaortic balloon pulsation; COPD,
chronic obstructive pulmonary disease.
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Staffing has to be flexible and responsive to volume;
overhead mainly relates to square footage; supply costs
are best affected through consortium purchasing and
standardization; and time is a surrogate for complications.
We can reduce costs by educating ourselves and using
good judgment. The most important strategies are these:
(1) outpatient diagnostics and same-day admissions for all
patients; (2) stratification of preoperative risk for appro-
priate selection and preparation; (3) minimization of
intensive care unit time; (4) formulation of pathways of
care and use of flexible staffing; and (5) development and
use of a cost-accounting system to understand individual
costs. Understanding each surgeon’s cost will allow edu-
cation of the staff and lead to further savings.
In my experience, costs cannot effectively be slashed
arbitrarily. Cost reduction has to be accomplished
thoughtfully and methodically. Try to gain savings in all
areas of inpatient and outpatient care as new technology
becomes available. The worst mistake we can make in a
hospital is to cut irreplaceable employees who could have
been reorganized to work more efficiently. It used to be
said that the greatest saving in medical care was death.
The authors point out that death can actually be very
expensive.
Dr. Ferraris, one of your main conclusions was to focus
future cost-containment strategies on this high-risk subset
of patients. Often these patients are elderly and have fixed
comorbidities, except for heart failure and anemia. Would
you comment further on how cost might be reduced, other
than by patient selection?
Dr. Jeffrey P. Gold (Bronx, N.Y.). Outcome, obviously,
is a lot more than just what occurs in the hospital. And
operative mortality and perioperative morbidity do not
necessarily provide the standard for long-term outcome
and quality of life. In our research, we found that periop-
erative neurologic morbidity, particularly stroke and
lesser degrees of neurologic injury, not only are major
predictors for hospital LOS and cost but also are the
major predictor for long-term quality of life and outcome.
Did your data reflect these same observations?
Dr. Javier Fernandez (Browns Mills, N.J.). We did a
similar study, which has been accepted for publication by
the European Journal of Cardio-Thoracic Surgery, involving
more than 5000 patients. Half of those patients were
younger than 65 years and half were older. Our purpose
was to compare preoperative risk factors, complication
rate, and charges as a function of age. We found a
significant increase in morbidity in the elderly population,
older than 65 years. Among the most important morbid-
ities were pulmonary complications that resulted in in-
creased LOS. Did you find pulmonary complications to be
an important factor that increases the LOS and costs?
Dr. Ferraris. As Dr. Loop points out, this is a complex
topic. One of the things that we learned early on is that
costs are hospital specific. I will try to answer some of the
discussants’ questions in sort of a global way.
First is the issue of how we might reduce costs. It is true
that there is a prototype of patient at whom you can look,
as an experienced surgeon, and say that this patient is
going to require increased time in the intensive care unit
and increased cost. There are a limited number of things
that may be done to intervene. One approach we have
taken has to do with modification of the inflammatory
response after bypass. Things that we have thought of that
might reduce this inflammatory response are serum pro-
tease inhibitors and more biocompatible oxygenator cir-
cuits. We are in the process of trying to organize clinical
trials that may affect patients at high risk.
The other questions about stroke and pulmonary com-
plications and how they affect cost are difficult to answer.
For example, in our study, stroke was not a particularly
high-cost item. I have a feeling that this is a hospital-
specific finding. Many of our patients with stroke may
move out of the hospital rather rapidly compared with
other hospitals. That they are discharged and go to a
rehabilitation center means that their costs are decreased
for our hospital’s purposes, but does not necessarily mean
that the costs are decreased for the system as a whole. I
think it is very difficult to answer, in a global way,
questions about stroke and pulmonary complications be-
cause many factors are hospital specific or surgeon spe-
cific. I hope this answers some of the discussants’ ques-
tions.
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